Form 4 Tracker
Ivan Hyep

Chief Financial Officer · 8 filings · Latest: Aug 10, 2026

Bicara Therapeutics Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
BCAX
Hyep IvanMar 3, 2026
Proposed Sale
$18.2213,555$246.9K
BCAX
Ivan HyepChief Financial OfficerJan 22, 2026
Sale
$18.151,882$34.2K145,355
BCAX
Ivan HyepChief Financial OfficerJan 22, 2026
Option Exercise
$3.791,882$7.1K147,237
BCAX
Hyep IvanJan 22, 2026
Proposed Sale
$18.151,882$34.2K
BCAX
Hyep IvanDec 22, 2025
Proposed Sale
$17.879,200$164.4K
BCAX
Hyep IvanNov 24, 2025
Proposed Sale
$18.5517,795$330.1K
BCAX
Hyep IvanNov 21, 2025
Proposed Sale
$18.15605$11.0K
BCAX
Hyep IvanOct 9, 2025
Proposed Sale
$17.896,415$114.8K
BCAX
Hyep IvanOct 8, 2025
Proposed Sale
$18.175,627$102.2K
BCAX
Hyep IvanOct 7, 2025
Proposed Sale
$18.0018,244$328.4K
BCAX
Hyep IvanOct 6, 2025
Proposed Sale
$17.046,514$111.0K

← Previous

Page 2 of 2